111 related articles for article (PubMed ID: 4699088)
1. Comparison of the accuracy of different types of dissolution rate methods.
Bolhuis GK; Lerk CF; Zuurman K
Pharm Weekbl; 1973 Jan; 108(3):49-53. PubMed ID: 4699088
[No Abstract] [Full Text] [Related]
2. [Effect of formulation of enterosoluable preparations on the physiologic availability of the active principle. 1: Effect on the rate of liberation of acetylsalicylic acid from enteric tablets on absorption characteristics in vivo].
Delporte JP; Jaminet F
J Pharm Belg; 1975; 30(2):99-113. PubMed ID: 1206458
[No Abstract] [Full Text] [Related]
3. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
[TBL] [Abstract][Full Text] [Related]
4. Class experiment with student volunteers illustrating the influence of formulation on absorption of aspirin [proceedings].
Luscombe DK; Nicholls PJ
Br J Pharmacol; 1976 Oct; 58(2):312P. PubMed ID: 974427
[No Abstract] [Full Text] [Related]
5. Coating of pharmaceuticals by phase separation of cellulose derivatives: preparation and in-vitro release.
Khalil SH; el-Gamal SS
Pharmazie; 1973 Jun; 28(6):385-8. PubMed ID: 4726397
[No Abstract] [Full Text] [Related]
6. [Influence of formulation of enterosoluble preparations on the physiologic disposition of the active principle. Part III. Establishment of quantitative correlations between the rate of dissolution in vitro of the active principle and its absorption characteristics].
Delporte JP
J Pharm Belg; 1976; 31(2):150-68. PubMed ID: 950582
[No Abstract] [Full Text] [Related]
7. Drug formulation and biologic availability.
Poole JW
Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
[No Abstract] [Full Text] [Related]
8. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
Dévay A; Mayer K; Pál S; Antal I
J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
[TBL] [Abstract][Full Text] [Related]
9. Is all aspirin alike?
Med Lett Drugs Ther; 1974 Jul; 16(14):57-9. PubMed ID: 4427568
[No Abstract] [Full Text] [Related]
10. Effects of moderate stress storage conditions on the dissolution profile of enteric-coated aspirin tablets.
Hoblitzell JR; Thakker KD; Rhodes CT
Pharm Acta Helv; 1985; 60(1):28-32. PubMed ID: 3975235
[No Abstract] [Full Text] [Related]
11. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
Chakrabarti S; Belpaire F; Moerman E
Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets.
Ozeki Y; Ando M; Watanabe Y; Danjo K
J Control Release; 2004 Feb; 95(1):51-60. PubMed ID: 15013231
[TBL] [Abstract][Full Text] [Related]
13. [Peroral, compounded long-acting drugs. 3. Tablets coated with Eudragite retard].
Chalabala M; Starha L
Cesk Farm; 1970 Jun; 19(5):184-6. PubMed ID: 5448541
[No Abstract] [Full Text] [Related]
14. The effect of microencapsulation with ethyl cellulose upon the disintegration in vivo and the dissolution of iron tablets.
Dahlström H; Eriksson S
Acta Pharm Suec; 1971 Nov; 8(5):505-8. PubMed ID: 5159520
[No Abstract] [Full Text] [Related]
15. Tableting research and technology.
Cooper J; Rees JE
J Pharm Sci; 1972 Oct; 61(10):1511-55. PubMed ID: 4561201
[No Abstract] [Full Text] [Related]
16. [Manufacturing delayed action tablet using sugar cane wax].
Orbán E; Isaura LV
Acta Pharm Hung; 1973 Jan; 43(1):9-13. PubMed ID: 4687825
[No Abstract] [Full Text] [Related]
17. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
Ibekwe VC; Fadda HM; Parsons GE; Basit AW
Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
[TBL] [Abstract][Full Text] [Related]
18. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
Tomassini L; Naplatanova D
Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
[No Abstract] [Full Text] [Related]
19. Characterizing process effects on pharmaceutical solid forms using near-infrared spectroscopy and infrared imaging.
Roggo Y; Jent N; Edmond A; Chalus P; Ulmschneider M
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):100-10. PubMed ID: 16005618
[TBL] [Abstract][Full Text] [Related]
20. [Enteric aspirin tablets and the salicylate concentration in the plasma in the morning].
Laine V; Strandman D; Tikkanen R
Lakartidningen; 1968 Sep; 65(39):3832-7 passim. PubMed ID: 5741894
[No Abstract] [Full Text] [Related]
[Next] [New Search]
